Center for Cardiovascular Genetics, Institute of Molecular Medicine and Department of Medicine, University of Texas Health Sciences Center at Houston, Houston, Texas, USA.
Circ Res. 2011 Dec 9;109(12):1342-53. doi: 10.1161/CIRCRESAHA.111.255075. Epub 2011 Oct 20.
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a disease of desmosome proteins characterized by fibroadipogenesis in the myocardium. We have implicated signaling properties of junction protein plakoglobin (PG) in the pathogenesis of ARVC.
To delineate the pathogenic role of PG in adipogenesis in ARVC.
We generated mice overexpressing PG, either a wildtype (PG(WT)) or a truncated (PG(TR)), known to cause ARVC, in the heart; and PG null (PG⁻/⁻) embryos. PG(WT) and PG(TR) mice exhibited fibro-adiposis, cardiac dysfunction, and premature death. Subcellular protein fractionation and immunofluorescence showed nuclear localization of PG(WT) and PG(TR) and reduced membrane localization of PG(TR). Coimmunoprecipitation showed reduced binding of PG(TR) but not PG(WT) to desmosome proteins DSP and DSG2. Transgene PG(WT) and PG(TR) were expressed in c-Kit+:Sca1+ cardiac progenitor cells (CPCs) isolated from the hearts of PG(WT) and PG(TR) by fluorescence activated cell sorting. CPCs isolated from the transgenic hearts showed enhanced adipogenesis, increased levels of adipogenic factors KLF15, C/EBP-α and noncanonical Wnt5b, and reduced level of CTGF, an inhibitor of adipogenesis. Treatment with BIO activated the canonical Wnt signaling, reversed the proadipogenic transcriptional switch and prevented adipogenesis in a dose-dependent manner. Moreover, c-Kit+ CPCs, isolated from PG⁻/⁻ embryos, were resistant to adipogenesis, expressed high mRNA levels of CTGF and other canonical Wnt signaling targets.
Nuclear PG provokes adipogenesis in c-Kit+ CPCs by repressing the canonical Wnt signaling and inducing a proadipogenic gene expression. The findings suggest that adipocytes in ARVC, at least in part, originate from c-Kit+ CPCs.
致心律失常性右室心肌病(ARVC)是一种桥粒蛋白病,其特征为心肌纤维-脂肪化生。我们已经发现桥粒蛋白斑蛋白(PG)的信号特性与 ARVC 的发病机制有关。
阐明 PG 在 ARVC 脂肪生成中的致病作用。
我们生成了心脏过表达野生型(PG(WT))或截断型(PG(TR))PG 的小鼠,已知其可导致 ARVC,以及 PG 敲除(PG⁻/⁻)胚胎。PG(WT)和 PG(TR)小鼠表现出纤维-脂肪化生、心脏功能障碍和早逝。亚细胞蛋白分离和免疫荧光显示 PG(WT)和 PG(TR)的核定位和 PG(TR)的膜定位减少。共免疫沉淀显示 PG(TR)而不是 PG(WT)与桥粒蛋白 DSP 和 DSG2 的结合减少。荧光激活细胞分选从 PG(WT)和 PG(TR)心脏中分离的 c-Kit+:Sca1+ 心脏祖细胞(CPCs)中表达转基因 PG(WT)和 PG(TR)。从转基因心脏中分离的 CPCs表现出增强的脂肪生成,脂肪生成因子 KLF15、C/EBP-α 和非经典 Wnt5b 的水平增加,以及脂肪生成抑制剂 CTGF 的水平降低。BIO 处理以剂量依赖性方式激活经典 Wnt 信号,逆转促脂肪生成的转录开关并防止脂肪生成。此外,PG⁻/⁻胚胎中分离的 c-Kit+CPCs对脂肪生成具有抗性,表达高水平的 CTGF 和其他经典 Wnt 信号靶标。
核 PG 通过抑制经典 Wnt 信号和诱导促脂肪生成基因表达来引发 c-Kit+CPC 中的脂肪生成。这些发现表明,ARVC 中的脂肪细胞至少部分来源于 c-Kit+CPCs。